Medtronic plc
MDT · CIK 0001613103 · Electromedical & Electrotherapeutic Apparatus
About Medtronic plc
We are a company of dedication, honesty, integrity, and service. Building on this strong foundation, we are embracing our role as a healthcare technology leader and evolving our business strategy in three key areas: •Accelerate innovation-driven growth: The combination of our attractive end markets, recent product launches and robust pipeline is expected to enable continued strong revenue growth.
Business information sourced from SEC annual filing filed Jun 18, 2026. Business descriptions reflect the cited filing and may not describe subsequent changes.
Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.
Financial highlights
Latest qualifying annual SEC observations · USDHistorical financial performance
USD billions · Annual SEC observations · Choose a metric
Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.
Annual financial history
USD · Exact fiscal period ends| Period ended | Revenue | Net income | Operating income | Assets | Liabilities | Cash | Operating cash flow | Net margin |
|---|---|---|---|---|---|---|---|---|
| April 24, 2026 | $36.36B | $4.80B | $6.47B | $93.03B | $42.96B | $1.95B | $7.33B | 13.2% |
| April 25, 2025 | $33.54B | $4.66B | $5.96B | $91.68B | $43.42B | $2.22B | $7.04B | 13.9% |
| April 26, 2024 | $32.36B | $3.68B | $5.14B | $89.98B | $39.56B | $1.28B | $6.79B | 11.4% |
| April 28, 2023 | $31.23B | $3.76B | $5.48B | $90.95B | $39.28B | $1.54B | $6.04B | 12.0% |
| April 29, 2022 | $31.69B | $5.04B | $5.75B | $90.98B | $38.26B | $3.71B | $7.35B | 15.9% |
| April 30, 2021 | $30.12B | $3.61B | $4.48B | $93.08B | $41.48B | $3.59B | $6.24B | 12.0% |
| April 24, 2020 | $28.91B | $4.79B | $4.79B | $90.69B | $39.82B | $4.14B | $7.23B | 16.6% |
| April 26, 2019 | $30.56B | $4.63B | $6.27B | $89.69B | $39.48B | $4.39B | $7.01B | 15.2% |
A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.
Company information
- Registered name
- Medtronic plc
- Ticker symbol
- MDT
- CIK
- 0001613103
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC SIC code
- 3845
- Fiscal year end (MMDD)
- 0424
- Last SEC synchronization
- Nov 7, 2026 19:23 UTC
- Headquarters / business address
- BUILDING TWO PARKMORE BUSINESS PARK WEST
GALWAY H91 4K49 - Mailing address
- BUILDING TWO PARKMORE BUSINESS PARK WEST
GALWAY H91 4K49 - Business phone
- 01135314381700
Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Last company information check: Nov 7, 2026 20:26 UTC. Official website, business descriptions and executive details require separate verification.
Latest SEC filings
Browse filings →| Form | Filed | Report period | Official source |
|---|---|---|---|
| 4 | Nov. 4, 2026 | Nov. 2, 2026 | View SEC filing ↗ |
| 11-K | Oct. 21, 2026 | Oct. 21, 2026 | View SEC filing ↗ |
| 11-K | Oct. 21, 2026 | Oct. 21, 2026 | View SEC filing ↗ |
| 4 | Oct. 21, 2026 | Oct. 15, 2026 | View SEC filing ↗ |
| 8-K | Oct. 19, 2026 | Oct. 15, 2026 | View SEC filing ↗ |
| 4 | Oct. 16, 2026 | Oct. 15, 2026 | View SEC filing ↗ |
| SCHEDULE 13G/A | Oct. 16, 2026 | View SEC filing ↗ | |
| 4 | Oct. 16, 2026 | Oct. 15, 2026 | View SEC filing ↗ |
| 4 | Oct. 16, 2026 | Oct. 15, 2026 | View SEC filing ↗ |
| 144 | Oct. 15, 2026 | View SEC filing ↗ | |
| 144 | Oct. 15, 2026 | View SEC filing ↗ | |
| 425 | Oct. 14, 2026 | View SEC filing ↗ | |
| SC TO-I/A | Oct. 14, 2026 | View SEC filing ↗ | |
| 425 | Oct. 13, 2026 | View SEC filing ↗ | |
| SC TO-I/A | Oct. 13, 2026 | View SEC filing ↗ | |
| 425 | Oct. 9, 2026 | View SEC filing ↗ | |
| 425 | Oct. 8, 2026 | View SEC filing ↗ | |
| 425 | Oct. 8, 2026 | View SEC filing ↗ | |
| SC TO-I/A | Oct. 8, 2026 | View SEC filing ↗ | |
| 425 | Oct. 8, 2026 | View SEC filing ↗ |
Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.